MedPath

Breast Cancer Self-Management Mobile Care Application Intervention in the Quality of Life

Not Applicable
Completed
Conditions
Breast Cancer
Quality of Life
Interventions
Other: BCSMS App
Registration Number
NCT04174248
Lead Sponsor
National Yang Ming Chiao Tung University
Brief Summary

The aim of this study was to investigate the quality of life (QoL) for women with breast cancer in Taiwan after using the BCSMS App.

Detailed Description

After receiving their first diagnosis of breast cancer, women with stage 0 to III were randomized into intervention and control groups. Intervention group subjects used BCSMS App and the control group subjects received usual care. Two questionnaires: EORTC QLQ-C30 and EORTC QLQ-BR 23 were distributed to subjects in both arms at baseline and at 1.5 and 3 months. All evaluations were anonymous.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
112
Inclusion Criteria
  • first diagnosis of breast cancer with stage 0 to III in past year.
  • aged 20 to 65 years
  • had an Android/iOS smartphone;
  • able to read and write in Chinese;
  • willing to participate in the study and provide informed consent.
Exclusion Criteria
  • not matched to inclusion criteria
  • mental illness
  • serious illness and life-threatening

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental groupBCSMS AppExperimental group with BCSMS App using
Primary Outcome Measures
NameTimeMethod
Baseline EORTC QLQ-C30Baseline

Baseline Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer Quality of Life -Core 30 (version 3). The minimum and maximum values are 0 and 100, and higher scores mean a better outcome.

Change of EORTC QLQ-C30 at 3 monththe 3rd month

Change from baseline Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer Quality of Life -Core 30 (version 3) to the 3rd month. The minimum and maximum values are 0 and 100, and higher scores mean a better outcome.

Change of EORTC QLQ-C30 at 1.5 month1.5 month

Change from baseline Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer Quality of Life -Core 30 (version 3) to 1.5 month.The minimum and maximum values are 0 and 100, and higher scores mean a better outcome.

Secondary Outcome Measures
NameTimeMethod
Baseline EORTC QLQ-BR23Baseline

Baseline Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer Quality of Life -Breast 23 (version 3). The minimum and maximum values are 0 and 100, and higher scores mean a better outcome.

Change of EORTC QLQ-BR23 at 1.5 month1.5 month

Change from baseline Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer Quality of Life -Breast 23 (version 3) to 1.5 month. The minimum and maximum values are 0 and 100, and higher scores mean a better outcome.

Change of EORTC QLQ-BR23 at 3 monththe 3rd month

Change from baseline Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer Quality of Life -Breast 23 (version 3) to the 3rd month. The minimum and maximum values are 0 and 100, and higher scores mean a better outcome.

Trial Locations

Locations (1)

National Yang-Ming University

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath